-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1306.pdf
June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … Helminthic therapy (pig whipworm) for treatment-resistant ulcerative colitis No high-impact potential … POEM was ineffective in
three patients because of severe submucosal fibrosis attributed to previous therapies … Finally, one
expert representing a clinical perspective stated that no therapies are available to promote
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/anxiety-children_research-protocol.pdf
September 12, 2016 - patient-centered outcomes, including remission, anxiety symptoms, behavioral
problems, parent distress, therapeutic … Child Interaction Therapy
§ Problem solving therapy (PST)
§ Third wave (Mindfulness) therapies
• … Child Interaction Therapy
§ Problem solving therapy (PST)
§ Third wave (Mindfulness) therapies
• … wave (Mindfulness)
therapies
o Acceptance and
Commitment Therapy
o Mindfulness Based
Cognitive … , Achenbach Child
Behavior Checklist), parental
overprotection,
accommodation, parent
distress, therapeutic
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_executive.pdf
January 01, 2011 - test is usually
determined by its indirect effect on outcomes, that is,
through its influence on therapeutic … regimen (i.e., repletion or continuous
treatment)
• Interactions between treatments (i.e., patients … – Most of the reported harms were attributed to iron therapy.
Key Question 3. … technical and clinical validity, to the assessment of test
impact on clinicians’ diagnostic thinking and therapeutic … regimen (i.e., repletion or continuous treatment)
– Interactions between treatments (i.e., patients
-
effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - As the first class of
new therapies for HCV treatment in 20 years and the first class of direct-acting … used only
after other treatments fail … As the first class of new therapies for HCV-infection treatment in 20 years and
the first class of … treatments
would significantly shift treatment or management models. … therapy was five prior to treatment.
-
effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
August 27, 2012 - Institute. www.rti.org
The Use of Conjoint Analysis to Elicit
Patient Preferences in Selecting
Treatment … Preferences among treatment alternatives depend on
the relative importance of features. … Respondents state preferences for series of
constructed, hypothetical treatment alternatives … A Treatment B
PAIN
STIFFNESS
STOMACH
PROBLEMS
Occasional mild … Patients rank toxicity against progression-free survival in second-line
treatment of advanced renal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0075_03-10-2009.pdf
January 01, 2009 - The nominator
specifically mentions Remicade, Imuran, anti-inflammatories, and biologic therapies for … the treatment and management of Crohn’s disease. … Comparator(s): Comparisons of the above pharmacologic treatments. … What treatments or therapies, alone or in conjunction with one another, provide the
highest rate of … , and
the person’s response to previous medical treatments.
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , reduce
complications of therapy, and allow patients to initiate therapy sooner, which could slow … Key Facts: Current therapies for CF have improved median survival times, but patients with
CF … therapy, and chest therapy, if the drug halts disease progression. … United Therapeutics products. [internet].
-
effectivehealthcare.ahrq.gov/products/asthma-nonpharmacologic-treatment/thermoplasty-systematic-review
-
effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … New drug treatment options are needed for obese patients seeking
medical therapy for weight loss. … with antiobesity pharmacotherapies and potential
third-party payers’ unwillingness to cover these therapies … Goods Administration for inclusion in its therapeutic
goods registry for treating T2DM and obesity
-
effectivehealthcare.ahrq.gov/sites/default/files/considerations-for-statistical-chapter-10.pptx
January 01, 2013 - and is also unrelated to the confounders of the treatment-outcome relationship. … be used to essentially back out the effect of the treatment on the outcome. … However, difficult issues arise when both treatment and confounding variables vary over time. … The IPTW technique assumes that, at each treatment decision, the effect of treatment on the outcome is … unconfounded, given the past covariate and treatment history.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0262_05-11-2007.pdf
January 01, 2007 - What constitutes an adequate diagnostic evaluation on which to base treatment of
UI?
2. … How effective is pharmacologic treatment of UI?
3. … How effective is non-pharmacologic treatment of UI?
4. … Does site of care (office, hospital, nursing home) influence choice of best treatment?
5. … Does this make a clinical difference in response to treatment?
8.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0215_01-06-2010.pdf
January 01, 2010 - Document Completion Date: 8-13-10
1
Results of Topic Selection Process & Next Steps
Treatment … Nominator: Individual
Nomination
Summary:
The nominator questions whether there are any effective treatments … No recent systematic review or practice guidelines were identified that address the
treatment of RLS … Because of the numerous treatments that are FDA approved or available off-label
for this condition, … any harms of these treatments, particularly in specific subpopulations such as elderly
patients.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_clinician.pdf
May 01, 2016 - Psychological and behavioral therapy
interventions include cognitive behavioral therapy (CBT),
interpersonal … psychotherapy (IPT), and dialectical behavior
therapy (DBT). … BWL
therapy
2 170
BWL decreased BMI more than CBT at the end of treatment. ���
CBT decreased binge-eating … was likely managed
by a psychiatrist and psychological and behavioral
therapy treatments were likely … Behavioral weight-loss therapy
Treatment that incorporates various behavioral strategies, such
as caloric
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0587-131115.pdf
March 06, 2013 - Individuals with non-muscle invasive bladder cancer (stages Ta, T1,
and Tis)
Intervention(s): Intravesical therapies … cystoscopy approaches in the detection and management of NMIBC
Comparator(s): Various new and existing therapies … Initial treatment for this stage of
bladder cancer usually involves surgical removal of the tumor through … a cystoscope (called TURBT)
followed by adjuvant therapy Approximately a quarter of these cases will … There have been recent advances in the diagnosis, treatment, and management of the NMIBC.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0440_06-01-2011.pdf
January 01, 2011 - Staff-Generated PICO
Population(s): Cancer patients completing primary treatment, including adults … cancers, with the potential for improved survival; improvement in quality of life and
health due to treatment … of late or continuous treatment side effects or psychosocial
effects of having cancer; greater patient … Harms: Earlier initiation of treatment for cancer progression that does not increase
survival (thereby … shortening the asymptomatic period with no side effects of treatment);
more frequent screening with
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … , noting its potential to improve patient adherence to therapy recommendations and
simplify treatment … taking an injectable therapy (e.g., insulin). … A pathway to endoscopic bariatric therapies.
Gastrointest Endosc. 2011 Nov;74(5):943-53.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
January 01, 2016 - success
Nonressolution
of lesions
Adjuvant or
replacement
therapies or agents
KQ2
KQ3
5 … These 148 studies included 42 comparative
studies, 38 addressing effectiveness and harms of therapies … therapy is more effective than propranolol alone. … Effectiveness and Harms of Second-Line
Therapies Following Beta-Blockers or Corticosteroids
We did … since the advent of beta-blocker treatment in countries,
like the United States, where such treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0365_10-28-2010.pdf
January 01, 2010 - The nominator expressed
interest in how the effectiveness of treatments may differ by factors such as … initiation, patient preferences and therapeutic values, and demographic
characteristics; and whether … psychotherapy
(including groupings of trauma-focused vs. not), to include complementary and
alternative therapies … pharmacotherapy, general and
specific types of psychotherapy (including complementary and alternative therapies … initiation, patient preferences and therapeutic values, and demographic characteristics).
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
December 01, 2013 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … No
effective treatments are available to improve long-term nutritional absorption other than
intestinal … is refractory to current therapies, the experts agreed. … Endoscopic
therapies for gastroesophageal reflux disease
(GERD). Policy number: 2012T0322K.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief3-SUD.pdf
April 01, 2021 - Food and Drug Administration for treatment of
opioid use disorder include maintenance therapy with the … options include psychological therapies (e.g., cognitive behavioral therapy,
contingency management … These therapies aim to address behavioral aspects of the underlying substance use
disorder, improve … treatment. … Managing
chronic pain in the elderly: an overview of
the recent therapeutic advancements.